Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bellicum Pharmaceuticals
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
Columbia University
Mayo Clinic
Mayo Clinic